Sal B improved neurological dysfunction, reduced the size of cerebral infarcts and cerebral edema, and inhibited the inflammatory response following cerebral I/R injury by downregulating TLR4, p‐p38MAPK, p‐JNK, nuclear NF‐κB, and IL‐1β production. Here, NFKB1 is linked to brain infarction.